Astria Therapeutics Inc (ATXS)

01:16 AM

(ATXS) Long Term Investment Analysis - news.stocktradersdaily.com

01:16 AM

May 05, 2025

Astria Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

May 05, 2025

May 05, 2025

Invesco Ltd. Has $161,000 Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

May 05, 2025

May 02, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Lis - GuruFocus

May 02, 2025

May 02, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ATXS Stock News - GuruFocus

May 02, 2025

May 02, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

May 02, 2025

May 02, 2025

Wall Street analysts’ outlook for Astria Therapeutics Inc (ATXS) - Sete News

May 02, 2025

May 02, 2025

Financial Metrics Check: Astria Therapeutics Inc (ATXS)’s Ratios for Trailing Twelve Months - DWinneX

May 02, 2025

May 02, 2025

Brokers Set Expectations for ATXS FY2025 Earnings - Defense World

May 02, 2025

May 01, 2025

Breaking down ATXS’s current quarter earnings estimates - uspostnews.com

May 01, 2025

May 01, 2025

Astria Therapeutics Announces Publication of Navenibart Phase 1a - GuruFocus

May 01, 2025

May 01, 2025

Astria Therapeutics reports progress in HAE drug trial By Investing.com - Investing.com India

May 01, 2025

May 01, 2025

Astria Therapeutics reports progress in HAE drug trial - Investing.com

May 01, 2025

May 01, 2025

Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology - Business Wire

May 01, 2025

May 01, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Holdings Increased by Legal & General Group Plc - Defense World

May 01, 2025

May 01, 2025

Astria Therapeutics (ATXS) to Release Quarterly Earnings on Thursday - Defense World

May 01, 2025

May 01, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Position Increased by JPMorgan Chase & Co. - Defense World

May 01, 2025

May 01, 2025

Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference | ATXS Stock News - GuruFocus

May 01, 2025

May 01, 2025

Cantor Fitzgerald Upgrades Astria Therapeutics (NASDAQ:ATXS) to “Strong-Buy” - Defense World

May 01, 2025

Apr 30, 2025

Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference - Business Wire

Apr 30, 2025

Apr 29, 2025

Astria Therapeutics (ATXS) Receives Overweight Rating with Promi - GuruFocus

Apr 29, 2025

Apr 29, 2025

Cantor Fitzgerald Initiates Coverage of Astria Therapeutics (ATXS) with Overweight Recommendation - Nasdaq

Apr 29, 2025

Apr 26, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives $26.60 Consensus Price Target from Analysts - Defense World

Apr 26, 2025

Apr 25, 2025

Ratios Revealed: Decoding Astria Therapeutics Inc (ATXS)’s Financial Health - DWinneX

Apr 25, 2025

Apr 24, 2025

Astria Therapeutics Inc (ATXS) stock analysis: A simple moving average approach - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Geode Capital Management LLC Sells 2,770 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Apr 24, 2025

Apr 23, 2025

ATXS’s Stock Dilemma: Astria Therapeutics Inc’s Market Performance and Outlook - investchronicle.com

Apr 23, 2025

Apr 21, 2025

Top Premarket Decliners - marketscreener.com

Apr 21, 2025

Apr 16, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Purchased by Vanguard Group Inc. - Defense World

Apr 16, 2025

Apr 14, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Bought by American Century Companies Inc. - Defense World

Apr 14, 2025

Apr 13, 2025

KLP Kapitalforvaltning AS Takes Position in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Apr 13, 2025

Apr 06, 2025

Raymond James Financial Inc. Takes $707,000 Position in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Apr 06, 2025

Apr 04, 2025

Long Term Trading Analysis for (ATXS) - news.stocktradersdaily.com

Apr 04, 2025

Apr 03, 2025

Teacher Retirement System of Texas Makes New Investment in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Apr 03, 2025

Apr 02, 2025

Astria Therapeutics Grants $235K Worth of Stock Options to Strategic New Hires - Stock Titan

Apr 02, 2025

Apr 01, 2025

Analysts Set Astria Therapeutics, Inc. (NASDAQ:ATXS) PT at $26.60 - Defense World

Apr 01, 2025

Mar 30, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Purchased by Swiss National Bank - Defense World

Mar 30, 2025

Mar 28, 2025

Charles Schwab Investment Management Inc. Increases Stake in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Mar 28, 2025

Mar 25, 2025

(ATXS) Investment Report - news.stocktradersdaily.com

Mar 25, 2025

Mar 16, 2025

Q1 EPS Estimates for Astria Therapeutics Cut by Wedbush - The AM Reporter

Mar 16, 2025

Mar 15, 2025

What is HC Wainwright’s Forecast for ATXS Q1 Earnings? - Defense World

Mar 15, 2025

Mar 15, 2025

Lifesci Capital Has Pessimistic View of ATXS FY2025 Earnings - Defense World

Mar 15, 2025

Mar 15, 2025

Q1 EPS Forecast for Astria Therapeutics Decreased by Analyst - Defense World

Mar 15, 2025

Mar 14, 2025

Astria Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 14, 2025

Mar 14, 2025

(ATXS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Mar 14, 2025

Mar 12, 2025

Astria Therapeutics price target raised to $28 from $27 at Wedbush - TipRanks

Mar 12, 2025

Mar 12, 2025

Wedbush Adjusts Price Target on Astria Therapeutics to $28 From $27, Keeps Outperform Rating - Marketscreener.com

Mar 12, 2025

Mar 12, 2025

Astria Therapeutics (NASDAQ:ATXS) Given Buy Rating at HC Wainwright - Defense World

Mar 12, 2025

Mar 12, 2025

Astria Therapeutics Advances Clinical Trials and Financials - TipRanks

Mar 12, 2025

Mar 11, 2025

Astria Therapeutics: Promising Developments and Strategic Advancements Justify Buy Rating - TipRanks

Mar 11, 2025

Mar 11, 2025

Astria Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025

Mar 11, 2025

Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update - BioSpace

Mar 11, 2025

Mar 11, 2025

Astria Therapeutics: Promising Pipeline and Strong Financials Drive Buy Rating - TipRanks

Mar 11, 2025

Mar 11, 2025

Preclinical data reported for Astria’s anti-OX40 monoclonal antibody - BioWorld Online

Mar 11, 2025